John Neppl
Analyst · Barclays. Please go ahead
Thanks, Greg and good morning everyone. Let’s turn to the earnings highlights on Slide 5. Our reported third quarter earnings per share, was $4.28 compared to $1.84 in the third quarter of 2020. Our reported results included a negative mark-to-market timing difference of $0.22 per share and a $0.78 per share gain on the sale of our U.S. interior grain elevators, which closed back in early July. Adjusted EPS was $3.72 in the third quarter versus $2.47 in the prior year. Adjusted core segment earnings before interest and taxes or EBIT were $698 million in the quarter versus $580 million last year, reflecting higher results in Agribusiness and Refined & Specialty Oils. In processing, higher results in North America, European soft seeds and our Asian and European destination soy value chains all benefited from improved margins. These were partially offset by lower results in South America, where margins were down from a strong prior year. In merchandising, improved performance was primarily driven by higher results in ocean freight due to strong execution and our global vegetable oil value chain, which benefited from increased margins. In Refined & Specialty Oils, the strong performance in the quarter was primarily driven by higher margins and volumes in North American refining, which continued to benefit from the recovery in foodservice and increased demand from the renewable diesel sector. Higher margins in Europe, largely driven by favorable product mix, also contributed to the improved performance. Results in South America and Asia were slightly higher than last year. In milling, lower results in the quarter were driven by Brazil, where higher volume and lower unit costs were more than offset by lower margins. Results in North America were comparable with last year. The increase in corporate expenses during the quarter was primarily related to performance-based compensation accruals. The gain in other was primarily related to our Bunge Ventures investment in Benson Hill, which went public during the quarter. Improved results for our non-core sugar and bio-energy joint venture were primarily driven by higher prices and sales volumes of ethanol and sugar. For the quarter, GAAP basis income tax expense was $92 million compared to $38 million for the prior year. The increase in income tax expense was due to higher pre-tax income. Net interest expense of $38 million was below last year, resulting from higher interest income related to the resolution of an historical value-added tax matter. Let’s turn to Slide 6. Here, you can see our continued positive EPS and EBIT trend adjusted for notable items and timing differences over the past four fiscal years, along with the most recent trailing 12-month period. This is an exceptional performance, and I echo Greg’s appreciation of the amazing execution by our global team. Slide 7 compares our year-to-date SG&A to the prior year. We achieved underlying addressable SG&A savings of $25 million, of which approximately 75% was related to indirect costs. Looking ahead, we are monitoring cost inflation globally and we will be working hard to offset this impact where we can while still making the necessary investments in our people, processes and technology. Moving to Slide 8, for the most recent trailing 12-month period, our cash generation, excluding notable items and mark-to-market timing differences, were strong with approximately $1.9 billion of adjusted funds from operations. This cash flow generation was well in excess of our cash obligations over the past 12 months, allowing us to continue to strengthen our balance sheet. Turning to Slide 9, during the quarter, we received two credit rating upgrades. Moody’s raised us to Baa2 and Fitch upgraded us BBB, both with stable outlooks. This now puts us at our target rating of BBB and Baa2 with all three rating agencies. The chart on this slide details our year-to-date capital allocation of adjusted funds from operations. After allocating $137 million to sustaining CapEx, which includes maintenance, environmental, health and safety, and $25 million to preferred dividends, we had approximately $1.1 billion of discretionary cash flow available. Of this amount, we paid $215 million in common dividends, invested $102 million in growth and productivity CapEx, and repurchased $100 million of common shares, leaving approximately $725 million of retained cash flow. Our pace of CapEx spend this quarter was below our expectations due to supply chain-related delays, which we don’t see improving by year end. As a result, we are reducing our 2021 CapEx forecast by about $100 million and we will be rolling over these projects into next year. In addition, we have a nice pipeline of growth and productivity investments that are under consideration, which will likely lead to a higher than baseline spend for the next couple of years. We will provide more details on our outlook during our Q4 earnings call in February. The $100 million of share repurchases in the quarter completed our $500 million authorization. As Greg mentioned earlier, Bunge’s Board has authorized a new $500 million program. Earlier this year, we increased our quarterly common dividend by 5%. In May of next year, we will again review our dividend with consideration for the recent increase in our earnings baseline from $5 to $7 per share and the success in strengthening our balance sheet. So, as we have been demonstrating, we will continue to take a balanced and disciplined approach to capital allocation. As you can see on Slide 10, by quarter end, readily marketable inventories exceeded our net debt by approximately $1.1 billion, a significant change from a year ago. Please turn to Slide 11. For the trailing 12 months, adjusted ROIC was 19.4%, 12.8 percentage points over our RMI adjusted weighted average cost of capital of 6.6%. ROIC was 13.7%, 7.7 percentage points over our weighted average cost of capital of 6% and well above our previously stated target of 9%. The spread between these metrics reflects how we use RMI and our operations as a tool to generate incremental profit. Moving to Slide 12, for the trailing 12 months, we produced discretionary cash flow of approximately $1.6 billion and a cash flow yield of 21.6%. The decline in cash flow yield from the prior year reflects a growth in book equity of the company. Please turn to Slide 13 and our 2021 outlook. As Greg mentioned in his remarks, taking into account our strong third quarter results and favorable market trends, we have increased our full year adjusted EPS from $8.50 to $11.50. Our outlook is based on the following expectations. In Agribusiness, results are expected to be up from our previous outlook and now forecasted to be higher than last year. In Refined & Specialty Oils, results are expected to be up from our previous outlook and well above last year. We continue to expect results in milling to be generally in line with last year. Excluding Bunge Ventures, corporate and other is expected to be lower than last year driven by higher performance based compensation, a portion of which was historically allocated to the segments. Additionally, the company now expects the following for 2021: an adjusted annual effective tax rate in the range of 15% to 17%; net interest expense in the range of $200 million to $210 million; capital expenditures in the range of $350 million to $400 million; and depreciation and amortization of approximately $420 million. In non-core, full year results in the Sugar & Bioenergy joint venture are now expected to be up considerably from the prior year. With that, I will turn things back over to Greg for some closing comments.